PA
AMP icon

PharVision Advisers’s Ameriprise Financial AMP Stock Holding History

PharVision Advisers’s Portfolio AMP Stock Details AMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-665
Closed -$326K – 121
2025
Q4 		$326K Buy
665
+211
+46% +$100K 0.17% 230
2025
Q3 		$223K Buy
+454
New +$233K 0.13% 414

Other funds holding AMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's AMP Position: Q1 2026 in Review

PharVision Advisers sold out of Ameriprise Financial (AMP) in Q1 2026, closing a stake of 665 shares — an estimated $326K sold.

PharVision Advisers first reported a position in AMP in Q3 2025 and held it in 2 quarters. The position peaked at $326K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AMP as of Q1 2026.

  • PharVision Advisers reported no remaining Ameriprise Financial position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 665 Ameriprise Financial shares in Q1 2026, an estimated $326K.
  • PharVision Advisers first reported a position in Ameriprise Financial in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Ameriprise Financial position peaked at $326K in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held Ameriprise Financial as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.